Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Total 13F shares
-
36,661,531
-
Share change
-
+2,234,518
-
Total reported value
-
$194,311,714
-
Put/Call ratio
-
27%
-
Price per share
-
$5.30
-
Number of holders
-
99
-
Value change
-
+$10,169,062
-
Number of buys
-
61
-
Number of sells
-
45
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2018
As of 30 Jun 2018,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,661,531 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, CITADEL ADVISORS LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, and ALKEON CAPITAL MANAGEMENT LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.